-
341
Challenges and Limitations of Endocrine Toxicity Evaluation in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy—Retrospective Study from a Tertiary-Level Hospital in...
Published 2023-05-01Subjects: “…endocrine immune-related adverse events (irAEs)…”
Get full text
Article -
342
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival
Published 2024-04-01Subjects: “…immune related adverse effects (irAEs)…”
Get full text
Article -
343
Tissue-resident memory T cells in immune-related adverse events: friend or foe?
Published 2023-12-01Subjects: Get full text
Article -
344
Editorial: Hallmark of cancer: tumor promoting inflammation
Published 2023-07-01Subjects: Get full text
Article -
345
-
346
Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity
Published 2024-03-01Subjects: Get full text
Article -
347
-
348
Preliminary Significant Wave Height Retrieval from Interferometric Imaging Radar Altimeter Aboard the Chinese Tiangong-2 Space Laboratory
Published 2021-06-01Subjects: “…interferometric imaging radar altimeter (InIRA)…”
Get full text
Article -
349
KOMUNITAS ANTIKEKERASAN SEKSUAL PADA ANAK. SAYAP PELINDUNG BAGI ANAK DARI ANCAMAN KEKERASAN SEKSUAL
Published 2017Get full text
Book Section -
350
Buklet sebagal Media pencegahan terhadap Kekerasan Seksual pada Anak-anak
Published 2011Get full text
Article -
351
-
352
-
353
-
354
Anti-tumor memory CD4 and CD8 T-cells quantified by bulk T-cell receptor (TCR) clonal analysis
Published 2023-03-01Get full text
Article -
355
Sphingosine-1-Phosphate Receptor Type 4 (S1P<sub>4</sub>) Is Differentially Regulated in Peritoneal B1 B Cells upon TLR4 Stimulation and Facilitates the Egress of Peritoneal B1a B Cells and Subsequent Accumulation of Splenic IRA B Cells under Inflammatory Conditions
Published 2021-03-01Subjects: “…innate response activator B cells (IRA B cells)…”
Get full text
Article -
356
Checkpoint Inhibitor-Induced Colitis—A Clinical Overview of Incidence, Prognostic Implications and Extension of Current Treatment Options
Published 2021-04-01Subjects: Get full text
Article -
357
PD-1 inhibitor-based adverse events in solid tumors: A retrospective real-world study
Published 2022-11-01Subjects: Get full text
Article -
358
Rapidly progressing dyspnea and retiform purpura
Published 2022-12-01Subjects: Get full text
Article -
359
Mechanism- and Immune Landscape-Based Ranking of Therapeutic Responsiveness of 22 Major Human Cancers to Next Generation Anti-CTLA-4 Antibodies
Published 2020-01-01Subjects: Get full text
Article -
360
Insights into Potential Pathogenesis and Treatment Options for Immune-Checkpoint Inhibitor-Related Pneumonitis
Published 2021-10-01Subjects: “…immune-related adverse events (irAEs)…”
Get full text
Article